Quarterly Results

202607 Results Summary

Revenue

The revenue stands at ₹ crore, reflecting a quarter-on-quarter *(QoQ) decrease of per cent from ₹ crore. This corresponds to a year-on-year *(YoY) decline of per cent.

Operating Profit

Operating Profit stands at ₹ crore, reflecting a quarter-on-quarter *(QoQ) decrease of per cent from ₹ crore. This corresponds to a year-on-year *(YoY) decline of per cent.

PBDT

PBDT stands at ₹ crore, reflecting a quarter-on-quarter *(QoQ) decrease of per cent from ₹ crore. This corresponds to a year-on-year *(YoY) decline of per cent.

Profit Before Tax

Profit Before Tax stands at ₹ crore, reflecting a quarter-on-quarter *(QoQ) decrease of per cent from ₹ crore. This corresponds to a year-on-year *(YoY) decline of per cent.

Net Profit

Net Profit stands at ₹ crore, reflecting a quarter-on-quarter *(QoQ) decrease of per cent from ₹ crore. This represents a per cent year-on-year *(YoY) decline for the same year.

  • YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.

Company News

More

Earnings

CategoryQ4 FY25-26Q4 FY24-25Change %FY25-26FY24-25Change %
Total Revenue8,853.348,382.125.6233,653.0831,723.736.08
Expenses7,102.996,622.397.2626,872.6825,172.636.75
Other Income117.04134.81-13.18493.61621.85-20.62
Operating Profit1,750.351,759.73-0.537,274.017,172.951.41
Depreciation478.57444.437.681,778.191,649.427.81
Interest98.21115.02-14.61383.97457.24-16.02
Profit Before Tax1,290.611,335.09-3.335,111.855,066.290.90
Tax369.77432.26-14.461,736.141,699.982.13
Net Profit920.84902.831.993,502.973,483.570.56
CategoryQ4 FY25-26Q3 FY25-26Change %
Total Revenue8,853.348,645.902.40
Expenses7,102.996,937.892.38
Other Income117.04188.01-37.75
Operating Profit1,750.351,708.012.48
Depreciation478.57464.732.98
Interest98.2192.775.86
Profit Before Tax1,290.611,338.52-3.58
Tax369.77428.72-13.75
Net Profit920.84909.801.21

Research Reports

ActionTarget Price (₹)BrokerDateReports
Data Not Found

Financial Reports

Data not available.

Stock Prices Compare with Peers

Company1 Day1 Week1 Month3 Months6 Month1 Year
Data Not Found

Corporate Information

Company News

Nandish Shah of HDFC Sec suggests Bear Spread on Nifty; key levels here

Nandish Shah of HDFC Securities has shared a Bear Spread strategy on Nifty, and a Bull Spread strategy on Aurobindo Pharma.

Updated On: 22 May 2026 | 7:03 AM IST

Stock picks: Analyst prefer Aurobindo Pharma, Sona BLW, Tata Steel

Stock picks: Ajit Mishra of Religare Broking recommends buying Aurobindo Pharma, Tata Steel & Sona BLW; here's why

Updated On: 14 May 2026 | 7:40 AM IST

Nifty Midcap Select index hits record high, rallies 13% in one month

The Nifty Midcap Select index hit a new high of 14,223.90, soaring 2% and surpassing its previous high of 14,118 touched on December 1, 2025.

Updated On: 06 May 2026 | 2:49 PM IST

Pharma cos brace for soft Q4; US drag persists; domestic growth cushions

Pharma sector may see a 7 per cent Y-o-Y growth in reported sales and a 1 per cent increase in Ebitda, led by steady ex-gRevlimid US sales, healthy domestic growth, and favourable forex movements

Updated On: 15 Apr 2026 | 7:57 AM IST

Ex-date alert! Aurobindo Pharma, 3 others to remain in spotlight next week

Notably, Indian equity markets will remain closed on Tuesday, April 14, on account of Dr Baba Saheb Ambedkar Jayanti.

Updated On: 10 Apr 2026 | 7:50 AM IST

Stocks to Watch today: Rate sensitives, Infosys, Aurobindo Pharma, GAIL

Stocks to Watch today, April 8, 2026: Banks, Real estate, automobiles, Infosys, Aurobindo Pharma are some of the key stocks to watch today

Updated On: 08 Apr 2026 | 7:27 AM IST

Stocks to Watch today: Godrej Consumer, Aurobindo Pharma, IRFC, PC Jeweller

Stocks to Watch today, April 7, 2025: Godrej Consumer, Aurobindo Pharma, IRFC, ACME Solar Holdings, PC Jeweller, and Titagarh Rail are some of the key stocks to watch today

Updated On: 07 Apr 2026 | 7:32 AM IST

Aurobindo Pharma sets April 12 as record date for ₹800 crore buyback

Company to repurchase up to 54.24 lakh shares at Rs 1,475 apiece through tender offer route, with promoters also eligible to participate in the buyback

Updated On: 06 Apr 2026 | 6:57 PM IST

Nifty Healthcare below 100-WMA, down 8% from its peak; what charts say?

Amol Athawale of Kotak Securities believes that the short-term outlook for Nifty Healthcare remains uncertain and sentiment may turn negative in case the index falls below 13,500 levels.

Updated On: 06 Apr 2026 | 11:19 AM IST

Astral, Glenmark, Nalco among high conviction F&O bets in April: Systematix

The futures & options market positioning reflects heavy short build-up, creating conditions for sharp but temporary short-covering rallies, says Systematix Institutional Equities.

Updated On: 01 Apr 2026 | 1:27 PM IST
More